Welcome at Lonza Netherlands

- Advanced Therapies -

Lonza Netherlands is a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe.

With a proven track record, Lonza Netherlands covers the full range of manufacturing services. Starting from Process Development and Clinical Trial Manufacturing from Phase I to Phase III, we are also equipped to support and manufacture commercial cell therapy products for the European market.

In order to help to unlock the potential of Cell Therapies for the benefit of patients Lonza Netherlands CMO services range from thorough transfer of technologies, QP release of products for the EU market, controlled temperature transportation to process development, including cell culture scale-up know-how and manufacturing of Advanced Therapeutic Medicinal Products.

Lonza Netherlands is located in the center of Europe and operates two state-of-the-art cGMP-licensed facilities for human cell & tissue culturing in Maastricht and Geleen (Netherlands). Lonza Netherlands two GMP Cell Manufacturing Facilities combine more than 4.500m² (55.000 sqft) offering the full range of flexibility and scalability. Lonza Netherlands international team consists of experts related to all quality aspects, manufacturing, engineering, process development and project management. Each department has a representative in a dedicated core team that is committed to your product manufacturing and becomes involved from the Technology Transfer onwards.

Due to our broad expertise and longstanding know-how and our two cell manufacturing Center of Excellence Lonza Netherlands is the CMO of choice for pharmaceutical and biotech companies, as well as academic institutions in this field.

How can we help you?

GMP Certification CMF Geleen

The Geleen Cell Manufacturing Facility was first GMP certified in 2012 by the Dutch authorities (IGZ).

Fact sheet

GMP Certification CMF Maastricht

Our Maastricht Cell Manufacturing Facility was first GMP certified in 2006 and has been successfully inspected by the Dutch Authorities (IGZ) on a regular basis thereafter.

Fact sheet